Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Completed 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Specimen Handling 78Cisplatin 66Carboplatin 64Drug Therapy 63Magnetic Resonance Spectroscopy 62Bevacizumab 62Radiotherapy 57Cyclophosphamide 56Gemcitabine 54pembrolizumab 52Capecitabine 50Oxaliplatin 49toripalimab 45Paclitaxel 41tislelizumab 40Standard of Care 39Biopsy 37fludarabine 36Injections 36Fluorouracil 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Docetaxel 28Surgical Procedures, Operative 27Leucovorin 27Irinotecan 27Dexamethasone 27Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Psychotherapy × 1 year × Clear all
NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Roswell Park Cancer Institute

Phase 2 Not yet recruiting
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡